|
Volumn 22, Issue 3, 2000, Pages 312-316
|
Why do men refuse or attend population-based screening for prostate cancer?
|
Author keywords
Evaluation studies; Mass screening; Prostatic neoplasms
|
Indexed keywords
PROSTATE SPECIFIC ANTIGEN;
ADULT;
AGED;
ANTIGEN SPECIFICITY;
ARTICLE;
CANCER SCREENING;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
HUMAN;
HUMAN CELL;
HUMAN TISSUE;
MAJOR CLINICAL STUDY;
MALE;
MULTICENTER STUDY;
PATIENT ATTITUDE;
PATIENT COMPLIANCE;
PRIORITY JOURNAL;
PROSTATE CANCER;
RANDOMIZED CONTROLLED TRIAL;
RECTUM BIOPSY;
SYMPTOMATOLOGY;
AGED;
HEALTH KNOWLEDGE, ATTITUDES, PRACTICE;
HUMANS;
MALE;
MASS SCREENING;
MIDDLE AGED;
MOTIVATION;
NETHERLANDS;
PATIENT ACCEPTANCE OF HEALTH CARE;
PROSTATIC NEOPLASMS;
QUESTIONNAIRES;
RANDOMIZED CONTROLLED TRIALS;
REGISTRIES;
SOCIOECONOMIC FACTORS;
TREATMENT REFUSAL;
|
EID: 0033778066
PISSN: 09574832
EISSN: None
Source Type: Journal
DOI: 10.1093/pubmed/22.3.312 Document Type: Article |
Times cited : (80)
|
References (22)
|